1Theilmann L, Stiehl A. Detection of large intrahepatic cholangiectases in patients with primary sclerosing cholangitis by endoscopic retrograde cholangiography [ J ]. Endoscopy, 1990, 22(1): 49-50.
2Berstad AE, Aabakken L, Smith HJ, et al. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis [ J ]. Clin Gastroenterol Hepatol, 2006, 4(4): 514-520.
4Olsson R, Boberg KM, de Muckadell OS, et al. High - dose ursodeoxycholic acid in primary sclerosing cholangitis : a 5 - year muhicenter, randomized, controlled study [J]. Gastroenterology, 2005, 129 (5): 1464-1472.
5Knox TA, Kaplan MM. Treatment of primary sclerosing cholangitis with oral methotrexate [J]. Am J Gastroenterol, 1991, 86(5) : 546 -552.
6Knox TA, Kaplan MM. A double - blind controlled trial of oral pulse methotrexate therapy in the treatment of primary selerosing chlangltis [J]. Gastroenterology, 1994, 106 (2): 494-499.
7Stiehl A, Rudolph G, Kloters - Plachky P, et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment [J]. J Hepatol, 2002, 36 (2): 151 -156.
8Brandsaeter B, Friman S, Broome U, et al. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries [J]. Scand J Gastroenterol, 2003, 38 ( 11 ) : 1176- 1183.
9Oldakowska - Jedynak U, Nowak M, Mucha K. Recurrence of primary sclerosing cholangitis in patients after liver transplantation[J]. Transplant Proc, 2006, 38 (1) : 240 -243.
5Clarke JD,Thuluvath PJ.Endoscopic frontiers in the field of hepa-tology[J].Minerva Gastroenterol Dietol,2007,53(1):101-109.
6Premoli A,Morello E,Bo S,et al.Diagnostic and therapeutic questions in overlap syndromes of autoimmune hepatitis[J].Minerva Gastroenterol Dietol,2007,53(1):79-82.
7Zetterquist H,Broomé U,Einarsson K,et al.HLA class Ⅱgenes in primary sclerosing cholangitis and chronic inflammatory bowel disease:no HLA-DRw52a association in swedish patients with sclerosing cholangitis[J].Gut,1992,33(7):942-946.
9Cruickshank SM,Southgate J,Wyatt JI,et al.Expression of CD4 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis[J].J Clin Pathol,1999,52(10):730-734.
10Vierling JM.Animal models for primary sclerosing cholangitis[J].Best Pract Res Clin Gastroenterol,2001,15(4):591-610.
